A carregar...
Ceftobiprole Perspective: Current and Potential Future Indications
Ceftobiprole combines an excellent spectrum for community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) pathogens, with a low/medium MDR risk, and the β-lactams’ safety in frail patients admitted to the hospital in internal medicine wards which may be at high risk of adverse events...
Na minha lista:
| Publicado no: | Antibiotics (Basel) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915564/ https://ncbi.nlm.nih.gov/pubmed/33567771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10020170 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|